HBW Insight speaks exclusively to CBD vape start-up Infused Amphora about the firm's recent UK market entry, the power of natural terpenes, the challenge of navigating the EU's complex regulatory landscape and how to reach consumers during a pandemic.
An estimated 7.3m people use CBD in the UK every year, according to cannabis market researchers, Prohibition Partners.
Given CBD’s popularity among British consumers – and the increasing complexity of European regulation of the ingredient in foods and food supplements – wellness manufacturers and retailers in the UK are diversifying into a range of applications beyond
Eleat's acquisition encompasses Clasado's Bimuno finished supplement product line and customer base, but not its Bimuno GOS proprietary galactooligosaccharide prebiotic ingredient.
Bayer Consumer Health hopes its new InflammAge saliva-based biomarker can help “revolutionize self-care and how people can manage their aging journey.”
Venture capital fund backed by Germany's Schwabe has €100m to invest in consumer health startups operating in categories such as sleep and mental health.
Biotech identifying and stabilizing RNA compounds that can be incorporated into dietary supplements will receive mentorship, strategy guidance and technical support from experts at Nestlé Health Science.
Herbalife expects little impact from increased tariffs on imports from China but strong boosts from acquiring Pro2col Health and Pruvit Ventures Inc. and 51% ownership of Link BioSciences.
Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.
US dietary supplement brand Nature's Bounty is yet to fully recover sales since supply issues forced it off shelves last year, according to Nestle's Q1 report.
